OVERVIEW

Substance and opioid use disorders remain critical public health concerns across the United States, affecting individuals of all demographics. In this 1-hour CME/CE webinar, Dr. Onyejekwe provides a clinically rich and actionable overview of both substance use disorder (SUD) and opioid use disorder (OUD), helping clinicians recognize early signs, reduce prescribing risks, and provide evidence-based treatment strategies.

Participants will explore the definitions, clinical presentations, and behavioral markers of SUD and OUD. The course also addresses the abuse potential of commonly prescribed drugs such as gabapentin and pregabalin. The core focus of the training is on patient-centered care through Medication-Assisted Treatment (MAT), including step-by-step procedures, medications used, and key resources for providers. This program serves as a vital educational stepping stone for providers unfamiliar with MAT protocols.

This course fulfills MATE DEA training requirements and satisfies state-mandated CE topics across controlled substance prescribing, opioid prescribing, substance use disorders, pain management, and behavioral health for physicians, nurses, and physician assistants in over 40 states.

Educational Objectives

  • Identify the clinical definitions and signs and symptoms associated with substance and opioid use disorders.
  • Understand the abuse potential of gabapentin and pregabalin and their implications in clinical settings.
  • Develop a patient-centered treatment strategy for managing substance and opioid use disorders.
  • Describe the Medication-Assisted Treatment (MAT) process and the pharmacologic options involved in treatment.

Who Should Take This Course

This course is designed for:

  • Physicians, Physician Assistants, and Nurses across states including Florida, Texas, Alaska, California, New Jersey, Indiana, Arizona, and more.
  • Providers seeking to fulfill CE requirements in Controlled Substance Prescribing, Substance Use Disorders, Opioid Prescribing, and Pain Management.
  • Clinicians are required to complete the MATE DEA training requirements for opioid prescribing.
  • Healthcare professionals involved in behavioral health, primary care, addiction medicine, and chronic pain management.

Did You Know?

  • Over 106,000 drug overdose deaths occurred in the U.S. in 2021, with opioids involved in approximately 75% of cases. [CDC, 2022]
  • Gabapentin and pregabalin are increasingly misused and have been associated with opioid overdose deaths. [JAMA Network, 2021]
  • Only 11% of people with opioid use disorder receive Medication-Assisted Treatment, despite its effectiveness. [SAMHSA, 2020]
  • MAT reduces the risk of overdose death by over 50% in individuals with opioid use disorder. [New England Journal of Medicine, 2018]
  • DEA's MATE Act requires all new and renewing DEA-registered prescribers to complete substance use disorder training beginning in 2023.

COURSE CONTENT

Substance and Opioid Use Disorders

Duration: 60 mins

Credits

Physician Accreditation Statement
eMedEd is an approved provider of continuing medical education by the Accreditation Council for Continuing Medical Education (ACCME), Provider #0008305. This activity is approved for 1 AMA PRA Category 1 Credits.


Nursing Accreditation Statement:
eMedEd is an approved provider of continuing nursing education by the California Board of Registered Nursing. Provider approved by the California Board of Registered Nursing, Provider #17890 for 1 contact hour.

Release Date:  May 01, 2025
Expiration Date: November 30, 2026

  • 1 AMA PRA Category 1 Credit™
  • 1 Contact Hours
  • TARGET AUDIENCE

    PhysicianNursingPhysician Assistant

    SPECIALITIES

    Family MedicineGeneral PracticeInternal MedicinePrimary CareFamily PracticeGeneral and Internal MedicineFamily and Patient Centered CareEmergency MedicineAddiction MedicinePsychiatryPain Management

    TERMS & CONDITIONS

    Disclosure Statement
    eMedEd ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, eMedEd identifies conflicts of interest with its instructors, planners, content managers, and other individuals who can control an activity's content. 

    All faculty, planners, and/or content managers have nothing to disclose, nor do they have any vested interests or affiliations.

    Disclaimer Statement 
    The content, views, and opinions presented in this educational activity are those of the faculty/authors and do not necessarily reflect those of eMedEd, Inc. The faculty/authors have disclosed if there is any discussion of published and/or investigational uses of agents that the FDA does not indicate in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

    If you have questions about continuing education credit or certificates related to this course, please contact us via email at contact@emeded.org

    Questions about the content, please contact eMedEd, Inc. via email at contact@emeded.org

    Copyright © 2024 eMedEd, Inc.  All rights reserved.  This material may not be reproduced, displayed, modified, or distributed without the express prior written permission of the copyright holder.

    REFUND, CANCELLATION POLICY & DISCLAIMER

    Refunds are subject to the following terms:

    • Eligibility: You may request a refund within 7 days of order confirmation only if none of the courses have been started (i.e., no course progress or completion has occurred).
    • Deductions: Refunds will be processed after deducting applicable online transaction charges.
    • Ineligibility: If any course in the bundle or individual course has been accessed or started, no refund will be issued, even within the 7-day window.
    • Course Expiry & Access: All purchased courses and bundles are accessible for the duration mentioned at the time of purchase. Unused access or non-completion does not qualify for a refund outside the eligible window.


    To request a refund, please email support@emedevents.com with your order details and reason for cancellation.

    DISCLAIMER

    eMedEvents neither represents any State Medical Board nor claims to provide any online course on behalf of the State Medical Board. Subscribing to any of our CME/CE online courses is entirely at the user's discretion, and they should verify with their State Medical Board for their current re-licensure requirements.

    REVIEWS (65)

    RELATED ONLINE COURSES

    Webcast

    Emergency Medicine
    22 AMA PRA Category 1 Credits™
    ...
    More actions
    US$199

    Webcast

    Emergency Medicine
    7.5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$149

    Webcast

    Emergency Medicine
    15 AMA PRA Category 1 Credits™
    ...
    More actions
    US$109